Aflibercept is a biologic medicine used in the treatment of several retinal and eye-related conditions. The Aflibercept Drug Market covers the therapeutic use and development of this medicine. Aflibercept works by inhibiting vascular endothelial growth factor, which can help control abnormal blood vessel growth and fluid leakage in the retina. It is administered through intravitreal injection by qualified healthcare professionals. Regular eye examinations and imaging can help monitor treatment response. Ongoing ophthalmology research continues to explore improved approaches to managing retinal diseases.
